A Comparative Study on the Pain Threshold Experienced by Fibromyalgia Patients Following Acute SARS-CoV-2 Infection
Open Access
Abstract
Significant gaps remain in the understanding of the etiology and pathogenesis of fibromyalgia (FM), and the COVID-19 pandemic has introduced even more unknowns. Social factors specific to that period, the viral infection itself, and/or vaccination are additional elements that can complicate the progression of the disease or the response to treatment. Aim: The primary hypothesis to be evaluated in this study is that an acute COVID-19 infection, even when considered recovered, may induce changes in the response to non-pharmacological treatment in FM patients, particularly concerning pain. Results: We included 128 patients diagnosed with FM before the pandemic began. The patients were divided based on their history of acute SARS-CoV-2 infection and COVID-19 vaccination status. All patients followed the same rehabilitation program (cognitive therapy, kinesitherapy). Perceived pain: The non-COVID-19 patient groups showed a statistically significant reduction in pain at the final evaluation compared to patients with a history of acute SARS-CoV-2 infection (p < 0.001). Algometric evaluation: Patients without COVID-19 infection and that were vaccinated exhibited the best improvement in pain threshold, both across evaluation times (p < 0.001) and compared to any of the other three groups studied (p < 0.001). Using the WHYMPI questionnaire, the same group of patients (those not having experienced acute COVID-19 and who were vaccinated) was the only group with a statistically significant improvement in pain severity (p = 0.009). In conclusion, to control and improve FM pain symptoms, in addition to appropriate medication, we propose paying additional attention to the history of acute SARS-CoV-2 infection and the COVID-19 vaccination status.Keywords
Funding Information
- Development of New Skills for Medical Students in Pandemic Context (2022-1-RO01-KA220-HED 000085385)
This publication has 49 references indexed in Scilit:
- Could the fibromyalgia syndrome be triggered or enhanced by COVID-19?Inflammopharmacology, 2023
- Evaluation of pain, disease activity, anxiety, depression, and neuropathic pain levels after COVID-19 infection in fibromyalgia patientsIrish Journal of Medical Science (1971 -), 2022
- Neurogenic inflammation in fibromyalgiaSeminars in Immunopathology, 2018
- Sleep Disorders and FibromyalgiaCurrent Pain and Headache Reports, 2011
- Tailored cognitive–behavioral therapy and exercise training for high‐risk patients with fibromyalgiaArthritis Care & Research, 2010
- The American College of Rheumatology Preliminary Diagnostic Criteria for Fibromyalgia and Measurement of Symptom SeverityArthritis Care & Research, 2010
- Reduced brain habituation to somatosensory stimulation in patients with fibromyalgiaArthritis & Rheumatism, 2006
- Comparison of Patients With Chronic Fatigue Syndrome, Fibromyalgia, and Multiple Chemical SensitivitiesArchives of internal medicine (1960), 1994
- The american college of rheumatology 1990 criteria for the classification of fibromyalgiaArthritis & Rheumatism, 1990
- Primary fibromyalgia (fibrositis): Clinical study of 50 patients with matched normal controlsSeminars in Arthritis and Rheumatism, 1981